荷兰研究理事会（the Dutch Research Council, NWO）和该国健康运动福利部共同设立450万欧元项目，研发AMR控制药物，共5个项目：
1. 靶向LspA的新药研发Targeting LspA: A novel approach to bacterial inhibition
2.更加安全的teixobactin衍生物研发：Safer antibiotics: Reducing kidney toxicity in Teixobactin
3.给予AI的新抗菌药物候选合物研究：PRIORITY: Unlocking new antibiotic candidates with AI
4.AI驱动的抗菌肽研究：AI-driven design of antimicrobial peptides
5.噬菌体内溶酶为基础的植入物抗感染研究：Endolysin-based implants to combat joint infections

加油！